Literature DB >> 7811262

Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.

A E Roher1, T C Kasunic, A S Woods, R J Cotter, M J Ball, R Fridman.   

Abstract

It has been recently reported that the 72 kDa proteolytic enzyme gelatinase A/type IV collagenase/matrix metalloproteinase 2 (MMP2) hydrolyzed the Lys 16-Leu 17 peptide bond of a synthetic decapeptide (YEVHHQKLVFF) representing the soluble A beta sequence of amino acid residues 10-20. Our aim was to test if this enzyme could also degrade the insoluble 40-42 residues long A beta peptides purified from Alzheimer Disease brain. Our results indicate that MMP2 hydrolyzes A beta 1-40 and A beta 1-42 peptides at Lys 16-Leu 17, at Leu 34-Met 35, and Met 35-Val 36 peptide bonds. These results suggest that MMP2 has the ability of degrading A beta of AD in vitro. If this hydrolysis also occurs in the brain's extracellular matrix, the enzymatic action of gelatinase a could prevent the generation of amyloidogenic A beta 1-40(42).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811262     DOI: 10.1006/bbrc.1994.2872

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1.

Authors:  E Levi; R Fridman; H Q Miao; Y S Ma; A Yayon; I Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

3.  Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.

Authors:  Erwin Cabrera; Paul Mathews; Emiliya Mezhericher; Thomas G Beach; Jingjing Deng; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-13       Impact factor: 5.187

Review 4.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

Review 5.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

6.  Oleuropein, an anti-oxidant polyphenol constituent of olive promotes α-secretase cleavage of the amyloid precursor protein (AβPP).

Authors:  Myrta Kostomoiri; Apostolia Fragkouli; Marina Sagnou; Leandros A Skaltsounis; Maria Pelecanou; Effie C Tsilibary; Athina K Tzinia
Journal:  Cell Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.046

7.  Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.

Authors:  Kathryn Aston-Mourney; Sakeneh Zraika; Jayalakshmi Udayasankar; Shoba L Subramanian; Pattie S Green; Steven E Kahn; Rebecca L Hull
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

8.  Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.

Authors:  Mei-Chen Liao; William E Van Nostrand
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

9.  Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels.

Authors:  Reinhilde Mlekusch; Christian Humpel
Journal:  Neurosci Lett       Date:  2009-09-26       Impact factor: 3.046

10.  Degradation of amyloid beta protein by purified myelin basic protein.

Authors:  Mei-Chen Liao; Mahiuddin Ahmed; Steven O Smith; William E Van Nostrand
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.